Industry Granules Life Sciences secures first U.S. FDA approval November 11, 2025 gopalkumarthakur@gmail.com The Granules India subsidiary’s Hyderabad site was subject of a PAI and following the go ahead plans to launch the product in the U.S. soon Related posts: AI algorithms can detect vision problems years before they actually appear, says ZEISS India How is the jewellery sector coping with U.S. tariffs? | Explained Capri Global to raise upto ₹400 crore via NCD issue Ashok Leyland Q2 net profit rises 7% to ₹756 crore; board declares interim dividend of ₹1 per share
